Do gifts from the pharmaceutical industry affect trust in physicians?

Family Medicine

Volumn 44, Issue 5, 2012, Pages 325-331

  Green, Michael J ^a   Masters, Rebecca ^a   James, Benjamin ^a   Simmons, Bree ^b,c   Lehman, Erik ^a  

^a Department of Humanities ^*  (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c ST VINCENT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOETHICS; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; DRUG INDUSTRY; ETHICS; FEMALE; GIFT GIVING; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL ETHICS; MIDDLE AGED; PHYSICIAN; PSYCHOLOGICAL ASPECT; TRUST; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; BIOETHICAL ISSUES; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG INDUSTRY; ETHICS, MEDICAL; FEMALE; GIFT GIVING; HUMANS; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; TRUST;

EID: 84862631491     PISSN: 07423225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Campbell EG, Gruen RL, Mountford J, Miller, LG, Cleary, PD, Blumenthal, D, A national survey of physician-industry relationships. N Engl J Med 2007;356:1742-1750.
2. Wazana A. Physicians and the pharmaceuticalindustry: is a gift ever just a gift? JAMA 2000; 283:373-380.
3. PhRMA. Code on interactions with healthcareprofessionals. http://www.phrma.org/code_on_interactions_with_healthcare_professionals. Accessed June 24, 2010.
4. Coyle SL. Physician-industry relations. Part 1:individual physicians. Ann Intern Med 2002; 136:396-402.
5. Brennan TA, Rothman DJ, Blank L, et al.Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006;295:429-433.
6. Paid to prescribe? Exploring the relationship between doctors and the drug industry. http://aging.senate.gov/hearing_detail.cfm?id=295808&. Accessed June 24, 2010.
7. Association of American Medical Colleges.Report of the AAMC Task Force on Industry Funding of Medical Education to the AAMC Executive Council. Washington, DC: AAMC, 2008.
8. Lo B, Field MJ, eds. Conflict of interest in medical research, education, and practice. Washington, DC: The National Academies Press, 2009.
9. Rothman DJ, Chimonas S. New developments in managing physician-industry relationships. JAMA 2008;300:1067-1069.
10. AMSA. AMSA PharmFree Scorecard. http://www.amsascorecard.org. Accessed June 24, 2010.
11. Brody H. The company we keep: why physicians should refuse to see pharmaceutical representatives. Ann Fam Med 2005;3:82-85.
12. Morgan MA, Dana J, Loewenstein G, Zinberg S, Schulkin J. Interactions of doctors with the pharmaceutical industry. J Med Ethics 2006; 32:559-563.
13. Steinman MA, Shlipak MG, McPhee SJ. Ofprinciples and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001;110: 551-557.
14. Huddle TS. Drug reps and the academic medical center: a case for management rather than prohibition. Perspect Biol Med 2008;51:251-260.
15. Pinto SL, Lipowski E, Segal R, Kimberlin C, Algina J. Physicians' intent to comply with the American Medical Association's guidelines on gifts from the pharmaceutical industry. J Med Ethics 2007;33:313-319.
16. Tonelli MR. Conflict of interest in clinical practice. Chest 2007;132:664-670.
17. Angell M. Drug companies and doctors: a storyof corruption. The New York Review of Books 2009;56. http://www.nybooks.com/articles/archives/2009/jan/15/drug-companies-doctorsastory-of-corruption/. Accessed June 24, 2010.
18. Jastifer J, Roberts S. Patients' awareness of and attitudes toward gifts from pharmaceutical companies to physicians. Int J Health Serv 2009;39:405-414.
19. Macneill PU, Kerridge IH, Newby D, Stokes BJ,Doran E, Henry DA. Attitudes of physicians and public to pharmaceutical industry "gifts." Intern Med J 2010;40:335-341.
20. Mainous AG III, Hueston WJ, Rich EC. Patientperceptions of physician acceptance of gifts from the pharmaceutical industry. Arch Fam Med 1995;4:335-339.
21. Gibbons RV, Landry FJ, Blouch DL, et al. Acomparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med 1998;13:151-154.
22. Blake RL Jr, Early EK. Patients' attitudesabout gifts to physicians from pharmaceutical companies. J Am Board Fam Pract 1995;8: 457-464.
23. DeAngelis CD. Conflict of interest and thepublic trust. JAMA 2000;284:2237-2238.
24. Goold SD. Trust, distrust and trustworthiness.J Gen Intern Med 2002;17:79-81.
25. Armstrong K, Rose A, Peters N, Long JA, McMurphy S, Shea JA. Distrust of the health care system and self-reported health in the United States. J Gen Intern Med 2006;21:292-297.
26. Shore DA, ed. The trust crisis in healthcare: causes, consequences, and cures. New York: Oxford University Press, 2007.
27. Weinfurt KP, Hall MA, Friedman JY, et al.Effects of disclosing financial interests on participation in medical research: a randomized vignette trial. Am Heart J 2008;156:689-697.
28. Hall MA, Camacho F, Lawlor JS, Depuy V, Sugarman J, Weinfurt K. Measuring trust in medical researchers. Med Care 2006;44:1048-1053.
29. Aghion P, Algan Y, Cahuc P, Shliefer A., Regulation and distrust. National Bureau of Economic Research, 2009. Working Paper 14648. http://www.nber.org/papers/w14648
30. Safran DG, Kosinski M, Tarlov AR, et al. Theprimary care assessment survey-tests of data quality and measurement performance. Med Care 1998;36:728-739.
31. Thom DH, Ribisl KM, Stewart AL, Luke DA, Further validation and reliability testing of the Trust in Physician Scale. The Stanford Trust Study Physicians. Med Care 1999;37:510-517.
32. O'Malley AS, Forrest CB, Mandelblatt J. Adherence of low-income women to cancer screening recommendations. J Gen Intern Med 2002;17: 144-154.
33. Association of American Medical Colleges. Thescientific basis of influence and reciprocity: a symposium. Washington, DC: AAMC, 2007.
34. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003;290:252-255.